Compass Therapeutics
CMPX
CMPX
55 hedge funds and large institutions have $401M invested in Compass Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
+17
Holders Change %
+44.74%
% of All Funds
0.89%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
19
Increased
22
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Blackstone Inc
New York
|
$23.2M |
| 2 |
VC
2
Vivo Capital
Palo Alto,
California
|
$17.9M |
| 3 |
BBA
3
Baker Bros. Advisors
New York
|
$7.83M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$18.2M |
| 5 |
5
Adage Capital Partners
Boston,
Massachusetts
|
$29M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CSS
51
Cubist Systematic Strategies
Stamford,
Connecticut
| $51.8K | +$51.8K | +10,300 | New |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $6K | +$6K | +1,160 | New |
|
53
Wells Fargo
San Francisco,
California
| $3.2K | +$900 | +179 | +39% |
|
54
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
55
Bank of America
Charlotte,
North Carolina
| $412 | +$412 | +82 | New |
|
56
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -675 | Closed |
|